The 'Celtic Tiger' roars again

Ireland's growth rates resemble its glory days a decade a go.

In 2010, Ireland almost went bust. Now its growth rates are back at levels reminiscent of the days of the Celtic Tiger' in the 2000s. GDP rose by 1.5% in the second quarter of 2014, or 6.5% year-on-year.

"Pretty much everything is heading in the right direction," as Philip O'Sullivan of Investec Ireland points out. Exports, crucial to Ireland's GDP, rose by 10% in the first half, while investment is now growing by 15% a year.

Even consumers, shattered by the collapse of the credit bubble, managed to increase spending by an annual 1.3% between April and June.

It helps that Ireland's two top trading partners, the US and the UK, are expanding at a healthy clip, while the euro has weakened and southern European borrowing costs have fallen as the threat of a euro break-up has receded.

But it's not just down to "the luck of the Irish", says the FT. Ireland has "taken the toughest of choices".

Large wage cuts in both the public and private sectors have restored competitiveness. The government also forced the banks to come clean about their losses, paving the way for a recovery in lending.

With public debt still at a "dangerous" 120% of GDP and a huge private debt burden, Ireland isn't out of the woods. But it is certainly peripheralEurope's poster child.

Recommended

How the Covid-19 vaccine crisis is putting the EU in danger
EU Economy

How the Covid-19 vaccine crisis is putting the EU in danger

The botched coronavirus vaccine campaign will cause long-term harm to the EU's economy, says Matthew Lynn.
4 Apr 2021
How the vaccine wars will harm us all
Global Economy

How the vaccine wars will harm us all

Grabbing and hoarding vaccine supplies, or even manufacturing one’s own, might seem to make sense for a state in an emergency. But the damage done to …
27 Mar 2021
The European Central Bank fumbles its way towards yield curve control
EU Economy

The European Central Bank fumbles its way towards yield curve control

The EU’s economic recovery is faltering, but its bond yields keep rising. That makes things tricky for the European Central Bank, says John Stepek. He…
12 Mar 2021
Vexing vaccine delays hit drug firms
Biotech stocks

Vexing vaccine delays hit drug firms

AstraZeneca and Pfizer are being attacked by the EU over what it claims are delays in delivering the Covid vaccine.
28 Jan 2021

Most Popular

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?
Bitcoin

Central banks are rushing to build digital currencies. What are they, and what do they mean for you?

As bitcoin continues to soar in value, many of the world’s central banks are looking to emulate it by issuing their own digital currencies. But centra…
8 Apr 2021
Nuclear power might never be popular – but now looks a good time to invest
Commodities

Nuclear power might never be popular – but now looks a good time to invest

Nuclear power gets a very bad press, but it is the ultimate renewable energy source. Interest in it is perking up again, says John Stepek. Which means…
9 Apr 2021
How to find companies that can thrive in the post-Covid world
Advertisement Feature

How to find companies that can thrive in the post-Covid world

Many sectors of the global economy will return to something resembling pre-pandemic status, but others will take far longer to recover.
8 Apr 2021